- Other Name
- ITN
- Sponsors Type
- Federal/National
- Country
- United States
- Grant Type
- Research Project
- Topics
- clinical trials immune tolerance allergy immunomodulation autoimmune research food allergies peanut allergy transplant immunology asthma immune function
Contact Info
- Phone
- (206) 342-6901
- Fax
- (206) 342-6588
- Address
- 1201 Ninth Avenue, Seattle, WA 98101-2795
Last modified on 2026-10-09 02:27:00
Description
**About Us**
The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Our mission is to accelerate the clinical development of immune tolerance therapies.
**ITN by the numbers**
- 62
total clinical trials -
Allergy trials;
Autoimmunity trials;
Transplant trials
14
total clinical trials -
Allergy trials;
Autoimmunity trials;
Transplant trials
26
total clinical trials -
Allergy trials;
Autoimmunity trials;
Transplant trials
22
total clinical trials -
Allergy trials;
Autoimmunity trials;
Transplant trials
- 235
clinical sites and investigators at leading academic hospitals worldwide
patients enrolled in ITN clinical trials
clinical specimens in the ITN repository
- 6022
clinical sites and investigators at leading academic hospitals worldwide
patients enrolled in ITN clinical trials
clinical specimens in the ITN repository
- 645907
clinical sites and investigators at leading academic hospitals worldwide
patients enrolled in ITN clinical trials
clinical specimens in the ITN repository
**Designing better studies through collaboration**
The ITN facilitates collaborative studies between academic, governmental and industry researchers in order to develop and fund cutting edge immune tolerance research that could not otherwise be conducted.
The ITN development model is a highly interactive process that capitalizes on our wide-ranging, multidisciplinary expertise, provided by an advisory board ([Network Steering Committee](https://www.immunetolerance.org/about-us/leadership)) of highly respected faculty from institutions world-wide. It begins with the [application process](https://www.immunetolerance.org/for-researchers/proposals) - from pre- and post-application support, to formal Q&A sessions with reviewers, we help investigators develop high quality research studies.
**Designing better studies through collaboration**
The ITN looks beyond the traditional clinical trial endpoints of safety and efficacy, actively investigating the mechanisms of tolerance induction and maintenance, developing clinical trials based upon mechanism-based hypotheses. In addition to clinical efficacy, ITN clinical trials validate tolerance mechanisms while also defining new biomarkers of tolerance in human disease. By taking this approach to our clinical trials and mechanistic research, we make sure that we learn something from every clinical trial to advance knowledge and get closer to cures -- no matter what the clinical outcome of the study.
Supported by an unprecedented array of [core facilities](https://www.immunetolerance.org/for-researchers/core-facilities), offering state-of-the-art genetic, cellular and immunologic assays, the ITN is generating some of the first combined clinical and mechanistic data on immune tolerance induction in humans.
Sponsor Relationship
Immune Tolerance Network is a part of:
No sponsor in our database are part of Immune Tolerance Network.
Most Recent Grants from This Sponsors
[Mechanistically Focused Clinical Trials in Environmental Allergy and...
Added on 2026-07-29
**Clinical Trials:** The Immune Tolerance Network (ITN) accepts applications for novel clinical...
Added on 2024-10-16
The Gauging Response in Allergic Rhinitis to Sublingual and Subcutaneous Immunotherapy...
Added on 2024-02-19
Deadline Approaching Grants
No grants from this sponsor have deadline within a month period.